Intrexon traded at $1.34 this Thursday June 30th, decreasing $0.02 or 1.47 percent since the previous trading session. Looking back, over the last four weeks, Intrexon lost 0 percent. Over the last 12 months, its price fell by 79.54 percent. Looking ahead, we forecast Intrexon to be priced at 1.36 by the end of this quarter and at 1.26 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agenus 1.94 -0.10 -4.90% -65.11%
Amgen 243.30 -2.13 -0.87% -1.46%
Anika Therapeutics 22.32 -0.19 -0.84% -49.81%
Arrowhead Research 35.21 0.65 1.88% -58.56%
AstraZeneca 10,800.00 -254.00 -2.30% 23.54%
Bluebird Bio 4.14 -0.44 -9.61% -87.23%
Bristol-Myers Squibb 77.00 -1.28 -1.64% 15.69%
ChemoCentryx 24.78 -0.71 -2.79% 87.73%
Gilead Sciences 61.81 -0.67 -1.07% -10.59%
GlaxoSmithKline 1,765.60 -27.40 -1.53% 22.78%
Heron Therapeutics 2.79 -0.38 -11.99% -81.40%
Immunogen 4.50 0.14 3.21% -31.71%
Incyte Corp 75.97 0.08 0.11% -9.58%
Karyopharm Therapeutics 4.51 0 0% -57.57%
Ligand Pharmaceuticals 89.22 0.74 0.84% -34.36%
MacroGenics 2.95 -0.07 -2.32% -89.54%
MannKind 3.81 0.01 0.26% -30.47%
Merck & Co 91.17 -1.34 -1.45% 16.90%
Novartis 80.85 -0.34 -0.42% -4.23%
Peregrine Pharmaceuticals 15.26 0.09 0.59% -42.55%
Rigel Pharmaceuticals 1.13 0.10 9.71% -74.89%
Roche Holding 318.55 -1.10 -0.34% -9.02%
Sangamo BioSciences 4.14 0 0% -65.53%
Thermo Fisher Scientific 543.28 7.36 1.37% 6.62%
Veracyte 19.90 -0.07 -0.35% -50.30%
Xencor 27.37 0.17 0.63% -23.29%
Intrexon 1.34 -0.02 -1.47% -79.54%
Ziopharm Oncology 1.24 0 0% -54.58%

Indexes Price Day Year
US2000 1708 -11.38 -0.66% -26.68%

Intrexon
Precigen, Inc. (Precigen) is a synthetic biology company that focuses on its discovery and clinical-stage activities to advance gene and cellular therapies to target immuno-oncology, autoimmune disorders, and infectious diseases. The Company is offering a class of microbe-based biopharmaceuticals that enable the expression and local delivery of disease-modifying therapeutics. Precigen is using precision technology to target intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. The Company also focused on studying life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications. The Company’s subsidiaries include PGEN Therapeutics, Inc., Precigen ActoBio, Inc., Exemplar Genetics, LLC and Trans Ova Genetics, L.C.